Article

Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug Classes

2017-05-01

Abstract excerpt

Depression and anxiety disorders are the first and sixth leading cause of disability worldwide according to latest reports from the World Health Organization. Despite their high prevalence and the significant disability resulted, there are limited advances in new drug development. On the other hand, the advent of genome-wide association studies (GWAS) has greatly improved our understanding of the genetic basis und...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2055ad63-4277-5c3c-878f-7ed22683cb56
DOI: 10.1101/132563

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug ClassesDOI 10.1101/132563Read

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersSemantic proximity Read

Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.Semantic proximity Read

Using genome-wide association results to identify drug repurposing candidatesSemantic proximity Read

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and CompoundsSemantic proximity Read

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Semantic proximity Read

Genetically informed drug target prioritisation and repurposing for major depressive disorderSemantic proximity Read

Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveriesSemantic proximity Read

Using genetic drug-target networks to develop new drug hypotheses for major depressive disorderSemantic proximity Read

Use of genome-wide association studies for drug repositioningSemantic proximity Read

Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposingSemantic proximity Read

Psychiatric Genome-wide Association Study Enrichment Shows Promise for Future Psychopharmaceutical DiscoveriesSemantic proximity Read

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.Semantic proximity Read